169 related articles for article (PubMed ID: 28087649)
21. [Construction of a human phage display ScFv library against Mycobacterium tuberculosis].
Yang H; Zhou XG; Shi L; Feng YH; Qin LH; Zheng RJ; Wang J; Hu ZY
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Sep; 31(9):682-5. PubMed ID: 19080570
[TBL] [Abstract][Full Text] [Related]
22. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
23. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.
Ozeki Y; Igarashi M; Doe M; Tamaru A; Kinoshita N; Ogura Y; Iwamoto T; Sawa R; Umekita M; Enany S; Nishiuchi Y; Osada-Oka M; Hayashi T; Niki M; Tateishi Y; Hatano M; Matsumoto S
PLoS One; 2015; 10(11):e0141658. PubMed ID: 26571296
[TBL] [Abstract][Full Text] [Related]
24. Secretome profile analysis of hypervirulent Mycobacterium tuberculosis CPT31 reveals increased production of EsxB and proteins involved in adaptation to intracellular lifestyle.
Vargas-Romero F; Guitierrez-Najera N; Mendoza-Hernández G; Ortega-Bernal D; Hernández-Pando R; Castañón-Arreola M
Pathog Dis; 2016 Mar; 74(2):. PubMed ID: 26733498
[TBL] [Abstract][Full Text] [Related]
25. Computational biology in anti-tuberculosis drug discovery.
Murphy DJ; Brown JR
Infect Disord Drug Targets; 2009 Jun; 9(3):319-26. PubMed ID: 19519485
[TBL] [Abstract][Full Text] [Related]
26. A whole genome bioinformatic approach to determine potential latent phase specific targets in Mycobacterium tuberculosis.
Defelipe LA; Do Porto DF; Pereira Ramos PI; Nicolás MF; Sosa E; Radusky L; Lanzarotti E; Turjanski AG; Marti MA
Tuberculosis (Edinb); 2016 Mar; 97():181-92. PubMed ID: 26791267
[TBL] [Abstract][Full Text] [Related]
27. Mycobacteriophages: an important tool for the diagnosis of Mycobacterium tuberculosis (review).
Fu X; Ding M; Zhang N; Li J
Mol Med Rep; 2015 Jul; 12(1):13-9. PubMed ID: 25760591
[TBL] [Abstract][Full Text] [Related]
28. Impact of proteomics on anti-Mycobacterium tuberculosis (MTB) vaccine development.
Jagusztyn-Krynicka EK; Roszczenko P; Grabowska A
Pol J Microbiol; 2009; 58(4):281-7. PubMed ID: 20380137
[TBL] [Abstract][Full Text] [Related]
29. Genomic and proteomic portrait of a novel mycobacteriophage SWU2 isolated from China.
Gong Z; Lv X; Li C; Gu Y; Fan X; Sun Q; Tong Y; Zhao F; Xing S; Pei G; Li Q; Xie L; Xie J
Infect Genet Evol; 2021 Jan; 87():104665. PubMed ID: 33279716
[TBL] [Abstract][Full Text] [Related]
30. Assessing the progress of Mycobacterium tuberculosis H37Rv structural genomics.
Fang Z; van der Merwe RG; Warren RM; Schubert WD; Gey van Pittius NC
Tuberculosis (Edinb); 2015 Mar; 95(2):131-6. PubMed ID: 25578513
[TBL] [Abstract][Full Text] [Related]
31. [Future prospects of molecular epidemiology in tuberculosis].
Matsumoto T; Iwamoto T
Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862
[TBL] [Abstract][Full Text] [Related]
32. The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.
Ezati N; Lukoye D; Wampande EM; Musisi K; Kasule GW; Cobelens FG; Kateete DP; Joloba ML
BMC Infect Dis; 2014 Dec; 14():703. PubMed ID: 25523472
[TBL] [Abstract][Full Text] [Related]
33. TGS-TB: Total Genotyping Solution for Mycobacterium tuberculosis Using Short-Read Whole-Genome Sequencing.
Sekizuka T; Yamashita A; Murase Y; Iwamoto T; Mitarai S; Kato S; Kuroda M
PLoS One; 2015; 10(11):e0142951. PubMed ID: 26565975
[TBL] [Abstract][Full Text] [Related]
34. Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis.
Allué-Guardia A; Saranathan R; Chan J; Torrelles JB
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450990
[TBL] [Abstract][Full Text] [Related]
35. In Silico identification of M. TB proteins with diagnostic potential.
Calero R; Mirabal M; Bouza J; Guzmán MV; Carrillo H; López Y; Norazmi MN; Sarmiento ME; Acosta A
BMC Immunol; 2013; 14 Suppl 1(Suppl 1):S9. PubMed ID: 23458073
[TBL] [Abstract][Full Text] [Related]
36. [Screening and analysis of in vivo induced genes of Mycobacterium tuberculosis].
Zhang ZD; Li ZH; DU BP; Jia HY; Liu ZQ; Chen X; Huang HR; Xing AY; Gu SX; Ma Y
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):189-93. PubMed ID: 18361819
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening.
Nayak K; Jing L; Russell RM; Davies DH; Hermanson G; Molina DM; Liang X; Sherman DR; Kwok WW; Yang J; Kenneth J; Ahamed SF; Chandele A; Murali-Krishna K; Koelle DM
Tuberculosis (Edinb); 2015 May; 95(3):275-87. PubMed ID: 25857935
[TBL] [Abstract][Full Text] [Related]
38. Genetic and mass spectrometric tools for elucidating the physiological function(s) of cytochrome P450 enzymes from Mycobacterium tuberculosis.
Ouellet H; Chow ED; Guan S; Cox JS; Burlingame AL; de Montellano PR
Methods Mol Biol; 2013; 987():79-94. PubMed ID: 23475669
[TBL] [Abstract][Full Text] [Related]
39. Tape measure protein having MT3 motif facilitates phage entry into stationary phase cells of Mycobacterium tuberculosis.
Dusthackeer A; Hassan VN; Kumar V
Comput Biol Chem; 2008 Oct; 32(5):367-9. PubMed ID: 18479969
[TBL] [Abstract][Full Text] [Related]
40. MTB-PCDB: Mycobacterium tuberculosis proteome comparison database.
Jena L; Wankhade G; Kumar S; Harinath BC
Bioinformation; 2011 Apr; 6(3):131-3. PubMed ID: 21584191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
